Literature DB >> 20165900

The dopamine D4 receptor: biochemical and signalling properties.

Pieter Rondou1, Guy Haegeman, Kathleen Van Craenenbroeck.   

Abstract

Dopamine is an important neurotransmitter that regulates several key functions in the brain, such as motor output, motivation and reward, learning and memory, and endocrine regulation. Dopamine does not mediate fast synaptic transmission, but rather modulates it by triggering slow-acting effects through the activation of dopamine receptors, which belong to the G-protein-coupled receptor superfamily. Besides activating different effectors through G-protein coupling, dopamine receptors also signal through interaction with a variety of proteins, collectively termed dopamine receptor-interacting proteins. We focus on the dopamine D4 receptor, which contains an important polymorphism in its third intracellular loop. This polymorphism has been the subject of numerous studies investigating links with several brain disorders, such as attention-deficit hyperactivity disorder and schizophrenia. We provide an overview of the structure, signalling properties and regulation of dopamine D4 receptors, and briefly discuss their physiological and pathophysiological role in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20165900     DOI: 10.1007/s00018-010-0293-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  196 in total

1.  Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants.

Authors:  V Jovanovic; H C Guan; H H Van Tol
Journal:  Pharmacogenetics       Date:  1999-10

2.  D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.

Authors:  C L Chio; R F Drong; D T Riley; G S Gill; J L Slightom; R M Huff
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

3.  Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

Authors:  L Toll; I P Berzetei-Gurske; W E Polgar; S R Brandt; I D Adapa; L Rodriguez; R W Schwartz; D Haggart; A O'Brien; A White; J M Kennedy; K Craymer; L Farrington; J S Auh
Journal:  NIDA Res Monogr       Date:  1998-03

4.  PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.

Authors:  A H Tang; S R Franklin; C S Himes; M W Smith; R E Tenbrink
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

5.  Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor.

Authors:  J N Oak; N Lavine; H H Van Tol
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 6.  Molecular diversity of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

7.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.

Authors:  Y Okuyama; H Ishiguro; M Toru; T Arinami
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

8.  Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning.

Authors:  J Amiel Rosenkranz; Anthony A Grace
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

9.  Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species.

Authors:  K J Livak; J Rogers; J B Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

10.  Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.

Authors:  Tara A Macey; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

View more
  33 in total

Review 1.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

Review 2.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

Review 3.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

4.  Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Authors:  Federica Bono; Paola Savoia; Adele Guglielmi; Massimo Gennarelli; Giovanna Piovani; Sandra Sigala; Damiana Leo; Stefano Espinoza; Raul R Gainetdinov; Paola Devoto; PierFranco Spano; Cristina Missale; Chiara Fiorentini
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

5.  The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-09-28       Impact factor: 4.530

Review 6.  Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache.

Authors:  Rodrigo Noseda; David Borsook; Rami Burstein
Journal:  Headache       Date:  2017-05       Impact factor: 5.887

7.  Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission.

Authors:  Tao Tan; Wei Wang; Jamal Williams; Kaijie Ma; Qing Cao; Zhen Yan
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

Review 8.  A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

Authors:  Jean-Martin Beaulieu
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

Review 9.  Dopamine D4 receptors in psychostimulant addiction.

Authors:  Patricia Di Ciano; David K Grandy; Bernard Le Foll
Journal:  Adv Pharmacol       Date:  2014

10.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.